Literature DB >> 8868943

[CAL 54, a new cell line derived from a human renal carcinoma: characterization and radiosensitivity].

J Gioanni1, E Zanghellini, C Mazeau, J Amiel, C Poustis-Delpont, J L Lagrange, H Duplay, C Caldani, A Courdi.   

Abstract

A new cell line (CAL 54) was isolated from a malignant pleural effusion of a patient with renal carcinoma. CAL 54 is a continuous and stable cell line. Immunochemical staining showed simultaneous expression of cytokeratin, epithelial membrane antigen and vimentin. Cytometric flow analysis of DNA content reveals one major hyperdiploid population. Histological aspect of the tumor induced in the nude mouse showed well differentiated adenocarcinoma with papillary structure. Radiation response of these cells was evaluated by the colony-forming method and the data were fitted with the linear-quadratic model. Survival at 2 Gy (SF2) was 0.28 and the mean inactivation dose (D) = 1.50 Gy, ranking this cell line among the radiation sensitive cells. CAL 54 may be an informative cell line to investigate radiation effects in the management of renal tumours.

Entities:  

Mesh:

Year:  1996        PMID: 8868943

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

Review 1.  Modeling clear cell renal cell carcinoma and therapeutic implications.

Authors:  Melissa M Wolf; W Kimryn Rathmell; Kathryn E Beckermann
Journal:  Oncogene       Date:  2020-03-02       Impact factor: 9.867

2.  Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy.

Authors:  Rola M Saleeb; Mina Farag; Zsuzsanna Lichner; Fadi Brimo; Jenni Bartlett; Georg Bjarnason; Antonio Finelli; Fabio Rontondo; Michelle R Downes; George M Yousef
Journal:  Mol Oncol       Date:  2018-08-23       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.